2021R0053/Fujian Provincial Department of Science and Technology[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Efficacy and safety of rituximab biosimilars or reference product as first-line treatment in patients with low-tumour-burden follicular lymphoma: A systematic review and meta-analysis.

Yang L, Zheng Z, Li N, Zheng B, Liu M, Cai H. Yang L, et al. J Clin Pharm Ther. 2022 Dec;47(12):1923-1931. doi: 10.1111/jcpt.13799. Epub 2022 Nov 7. J Clin Pharm Ther. 2022. PMID: 36345167 Review.

Cost-effectiveness analysis of axicabtagene ciloleucel vs. salvage chemotherapy for relapsed or refractory adult diffuse large B-cell lymphoma in China.

Li N, Zheng B, Cai H, Yang T, Hong Y, Liu M, Hu J. Li N, et al. Support Care Cancer. 2022 Jul;30(7):6113-6121. doi: 10.1007/s00520-022-07041-2. Epub 2022 Apr 14. Support Care Cancer. 2022. PMID: 35419735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters